Athari BioSciences
Athari BioSciences is a CLIA-certified BSL-2 diagnostic, research, and training laboratory advancing healthcare through scientific innovation in diagnostics, therapeutics, genomic research, and workforce development. With a mission focused on improving health equity, personalized medicine, and education, the company provides laboratory, research, and regulatory services, and offers hands-on learning experiences to foster the next generation of life sciences professionals.
Industries
Nr. of Employees
small (1-50)
Athari BioSciences
45925 Horseshoe Drive, Suite 170, Sterling, VA 20166
Products
A diagnostic platform measuring viral infectivity and host cell viability in parallel, with applications for immune monitoring and emerging pathogen surveillance.
Platform for real-time immunosurveillance and vaccine evaluation using safe, non-replicating virus-like particles to monitor immunity and variant-specific responses.
A diagnostic platform measuring viral infectivity and host cell viability in parallel, with applications for immune monitoring and emerging pathogen surveillance.
Platform for real-time immunosurveillance and vaccine evaluation using safe, non-replicating virus-like particles to monitor immunity and variant-specific responses.
Services
Comprehensive clinical laboratory testing including pharmacogenomic, infectious disease, and toxicology diagnostics, as well as CAP/CLIA advisory support for compliance and operations.
Research and development services for diagnostics and biopharma, including biomarker discovery, companion diagnostics, clinical trial support, and assay development.
Training, internships, and workforce development programs for students and professionals in life sciences, including mentorship, technical skill-building, and career support.
STEMM-focused educational and outreach initiatives for K-12, college students, and veterans to support learning, skill development, and community engagement in STEMM.
Consulting services to support laboratories and organizations in achieving CAP, CLIA, COLA, and ISO certification and maintaining quality and compliance standards.
Comprehensive clinical laboratory testing including pharmacogenomic, infectious disease, and toxicology diagnostics, as well as CAP/CLIA advisory support for compliance and operations.
Research and development services for diagnostics and biopharma, including biomarker discovery, companion diagnostics, clinical trial support, and assay development.
Training, internships, and workforce development programs for students and professionals in life sciences, including mentorship, technical skill-building, and career support.
STEMM-focused educational and outreach initiatives for K-12, college students, and veterans to support learning, skill development, and community engagement in STEMM.
Consulting services to support laboratories and organizations in achieving CAP, CLIA, COLA, and ISO certification and maintaining quality and compliance standards.
Expertise Areas
- Diagnostic development and validation
- Clinical trial management and support
- Pharmacogenomics and precision medicine
- Companion diagnostics
Key Technologies
- Molecular diagnostics
- Biomarker validation assays
- Flow cytometry
- PCR-based diagnostics
Key People
Founder & Chief Executive Officer
Chief Scientific Officer
Chief Medical Officer & Laboratory Director
Chief Operating Officer
Vice President, Marketing & Communications
Founder & Chief Executive Officer
Chief Scientific Officer
Chief Medical Officer & Laboratory Director
Chief Operating Officer
Vice President, Marketing & Communications
News & Updates
Received prize at a showcase event focused on equity-driven innovation.
Participated in a panel at a NASA leadership event.
Presented the neutralization and surveillance platform at a major vaccine industry event.
Discussion on the role of blood donations in supporting diagnostics, evolution of testing technologies, and introduction of dual-reporter diagnostic platforms.
Highlights insights from early-career scientists, emphasizing mentorship, training, and multidisciplinary innovation.
Leadership discusses mission and example R&D initiatives such as cancer therapeutics and oral vaccine platforms.
Received prize at a showcase event focused on equity-driven innovation.
Participated in a panel at a NASA leadership event.
Presented the neutralization and surveillance platform at a major vaccine industry event.
Discussion on the role of blood donations in supporting diagnostics, evolution of testing technologies, and introduction of dual-reporter diagnostic platforms.
Highlights insights from early-career scientists, emphasizing mentorship, training, and multidisciplinary innovation.
Leadership discusses mission and example R&D initiatives such as cancer therapeutics and oral vaccine platforms.